Table 1 Demographic and clinical characteristics of participants
Variables | Total cohort n = 128 | Lung cavitation n = 61 | No lung cavitation n = 64 |
|---|---|---|---|
Age (years), median (IQR) | 35 (29–41.2) | 33.0 (29–43) | 36 (30–41) |
Female, n (%) | 55 (43) | 28 (45.9) | 25 (39.1) |
Body mass index (kg/m2), median (IQR) | 20.2 (18.5–22.7) | 19.8 (17.9–21.5) | 20.5 (19.0–23.6) |
HIV Positive, n (%) | 93 (72.7) | 37 (60.7) | 53 (82.8) |
ARV statusa, n (%) | |||
No | 9 (7) | 4 (6.6) | 4 (6.2) |
Yes | 84 (65.6) | 33 (54.1) | 49 (76.6) |
Previous TB History, n (%) | |||
No | 77 (60.2) | 37 (60.7) | 38 (59.4) |
Yes | 51 (39.8) | 24 (39.3) | 26 (40.6) |
TB diagnosis | |||
RR/MDR | 115 (89.8) | 57 (93.4) | 56 (87.5) |
Pre-XDR/XDR | 13 (10.2) | 4 (6.6) | 8 (12.5) |
Alcohol use, n (%) | |||
No | 118 (92.2) | 53 (86.9) | 62 (96.9) |
Yes | 10 (7.8) | 8 (13.1) | 2 (3.1) |
Smoking, n (%) | |||
No | 120 (93.8) | 57 (93.4) | 60 (93.8) |
Yes | 8 (6.2) | 4 (6.6) | 4 (6.2) |
Lung cavities*, n (%) | |||
None | 64 (50) | - | 64 (100) |
Unilateral | 46 (35.9) | 46 (75.41) | - |
Bilateral | 15 (11.7) | 15 (24.59) | - |